Taspoglutide is primarily used in the management of type 2 diabetes. It functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, helping to regulate blood sugar levels by enhancing insulin secretion in response to meals. This action also slows gastric emptying, which contributes to better post-meal glucose control. Additionally, it aids in reducing appetite, which can be beneficial for weight management in diabetic patients. Its use is aimed at improving glycemic control while minimizing the risk of hypoglycemia, making it a valuable option for long-term diabetes care.